Search

The article explores the effects of 17-estradiol treatment on the endocrine system through single-nucleus transcriptomic sequencing of the hypothalamus in aged male Norway brown rats. The study reveals that 17-estradiol treatment attenuates cellular stress and metabolic changes associated with aging in neurons, impacting various functions related to food intake, reproduction, blood pressure, stress response, and electrolyte balance. The treatment also increases serum Oxytocin levels and activates the hypothalamic-pituitary-gonadal axis, with potential side effects observed in Crh neurons. The research suggests that the HPG axis and energy metabolism are key targets of 17-estradiol in the male hypothalamus, highlighting the importance of supervised clustering of neurons for treatment assessment. [Extracted from the article]

The article discusses the impact of vaginal estrogen therapy (VET) initiation on disease-free survival (DFS) in women with a history of non-metastatic breast cancer (BC). The study utilized data from the French National Health Data System to emulate target trials and found that VET initiation did not decrease DFS in patients with hormone receptor (HR)-positive tumors treated with tamoxifen. However, VET initiation might decrease DFS in patients treated with aromatase inhibitors, with estriol leading to a more pronounced decrease in DFS than promestriene. The preprint has not been peer-reviewed and provides valuable insights into the potential effects of VET on oncological outcomes in BC patients. [Extracted from the article]

The article discusses a clinical trial, NCT06657105, conducted by AstraZeneca to assess the effect of multiple doses of baxdrostat on the pharmacokinetics of a single dose of combined oral ethinyl estradiol and levonorgestrel in healthy female participants of non-childbearing potential. The study aims to evaluate the safety and tolerability of baxdrostat during the trial period. The trial is set to be completed by January 17, 2025, and will involve 48 participants. The study design is interventional, with a non-randomized allocation and a sequential intervention model. [Extracted from the article]

A study published in Health & Medicine Week explores the impact of knocking out the regulator of G-protein signaling 2 (RGS2) in CD4+ T cells on ovarian function and immune cell differentiation in female mice. The research found that RGS2 knockout in CD4+ T cells led to increased oocyte ovulation and higher levels of anti-inflammatory T cells in the ovary and uterus, along with elevated concentrations of estradiol and progesterone in the serum. The study suggests that RGS2 plays a crucial role in reproductive outcomes and calls for further investigation into its effects on fertility and implantation. [Extracted from the article]

Researchers at Yunnan Minzu University in Kunming, China, have developed a novel self-powered electrochemical biosensor for the precise detection of 17 beta-estradiol (E2) using enzymatic biofuel cells. The biosensor integrates dual-enzyme cascade amplification and bioconjugate technology, achieving exceptional sensitivity with a detection limit of 3.3 pg mL-1. This research has significant potential for applications in food and environmental safety, serving as a prototype for a mobile and on-site bioassay system. The study was funded by various organizations and has been peer-reviewed, offering valuable insights into emerging technologies in bioengineering and biotechnology. [Extracted from the article]

Researchers at Shanxi University in the People's Republic of China have developed a highly sensitive electrochemical aptasensor for detecting 17 beta-estradiol (E2) using gold particles (Au NPs) signal amplification. The sensor exhibited excellent analytical performance with high sensitivity, selectivity, and stability, with a detection limit for E2 of 0.053 pM and a linear response ranging from 0.1-200 pM. The research, funded by various organizations including the National Natural Science Foundation of China, concluded that the sensor showed promising results when applied to real environmental samples. This study was published in the Microchemical Journal and can be accessed for further information. [Extracted from the article]

A recent report from Jiangsu University in Zhenjiang, People's Republic of China, discusses the detection of 17 beta-Estradiol (E2) and its impact on human health and ecosystems. The study highlights the use of paper-based analytical devices (PADs) as promising tools for E2 detection due to their portability, cost-effectiveness, and rapid results. Despite significant progress, challenges such as sensitivity and commercial viability remain, and the research suggests a strategic roadmap for the future development and commercialization of PADs. For more information, readers can refer to the article "A Comprehensive Review of Paper-based Analytical Devices for 17b-estradiol Detection: Current Status and Future Perspectives" published in Microchemical Journal. [Extracted from the article]

A study conducted by Charite - University Medicine Berlin examined the effects of estradiol and progesterone administration on fear extinction in healthy pre-menopausal women. The research found that estradiol administration affected the extinction of conditioned fear responses, leading to a stronger return of fear. These findings suggest that estradiol levels may influence the success of exposure therapy in treating anxiety disorders. The study involved 116 women and was published in Translational Psychiatry in 2024. [Extracted from the article]

A study conducted by Universiti Kebangsaan Malaysia explored the estrogenic activity of Achyranthes aspera L. on estrogen-responsive breast cancer cells. The research identified twelve phenolics in the active fraction of Achyranthes aspera L., which showed potential interactions with the hERa receptor. The study suggests that Achyranthes aspera L. may have estrogenic properties and could be beneficial in managing menopausal-related issues. For more information, the full article can be accessed for free at https://doi.org/10.1016/j.heliyon.2024.e38792. [Extracted from the article]

A recent study conducted at the University of Michigan focused on the impact of relugolix combination therapy on functioning and quality of life in women with endometriosis-associated pain. The research, supported by Sumitomo Pharma Switzerland GmbH and Pfizer Inc., found that women treated with relugolix CT experienced significant improvements in pain domain scores and overall quality of life over a 104-week period. The study concluded that relugolix combination therapy led to sustained reduction of endometriosis-associated pain and improvements in functioning and health-related quality of life. [Extracted from the article]

A recent study conducted at Shiraz University of Medical Sciences in Iran explored the effects of L-tartaric acid on ovarian histostereological and hormonal changes in an animal model of Polycystic Ovary Syndrome (PCOS). The study found that PCOS led to significant alterations in ovarian tissue and hormone levels, but the administration of tartaric acid helped restore these effects. The research suggests that tartaric acid could be a potential novel strategy for managing PCOS, although further studies are needed to confirm these findings. [Extracted from the article]

A recent study conducted at Charite University Hospital and School of Medicine in Berlin, Germany, explored the predictive value of estradiol (E2) related parameters on the incidence of gestational diabetes mellitus (GDM) in women undergoing fresh embryo transfer. The study identified an optimal E2/follicle (E2/F) ratio threshold of 246.03 pg/ml on the day of human chorionic gonadotropin (hCG) administration, which was associated with lower rates of GDM and ovarian hyperstimulation syndrome (OHSS). The research concluded that an E2/F ratio over 246.03 pg/ml is significantly linked to a reduced risk of both GDM and OHSS, making it a superior predictive biomarker compared to other E2-related parameters. [Extracted from the article]

A recent study conducted at Omsk State Pedagogical University in Russia focused on the expression of the MUC1 family of transmembrane glycoproteins in breast cancer patients. The research found that levels of MUC1 in the saliva of patients with HER2-positive breast cancer were significantly lower compared to healthy controls. The study also highlighted a correlation between aggressive tumor growth, high levels of pro-inflammatory cytokines, low levels of free estradiol, and suppressed expression of salivary MUC1. For more information, the full article is available in the journal Cancers. [Extracted from the article]

A recent study from the University of the West of Scotland explores the role of estrogen in breast cancer development. The research suggests that estrogen may have both tumor-promoting and anti-inflammatory effects by influencing the expression of certain receptors. The study highlights the potential for novel cancer therapies by understanding the interplay between estrogen receptors and atypical chemokine receptors. For more information, readers can refer to the article "Down regulation of estrogen receptors and atypical chemokine receptors to increase 17b-estradiol levels in MCF-7 in-vitro study" in Basic & Clinical Cancer Research. [Extracted from the article]

Researchers at the University of Kisangani conducted a study comparing the effectiveness of sildenafil citrate and estradiol valerate as adjuvants during ovarian stimulation cycles with clomiphene citrate in patients with unexplained infertility. The study involved 148 patients and found that sildenafil citrate increased the clinical pregnancy rate more than estradiol valerate in this population. The research was published in Contraception and Reproductive Medicine and is available for further reading. [Extracted from the article]

A recent study conducted at the University of Southern Florida explored the impact of ovariectomy and estradiol on spatial memory impairment in tumor-bearing MMTV-PyVT mice undergoing chemotherapy. The research suggests that chemotherapy-induced ovarian damage and decreased estrogen levels may contribute to cognitive deficits, emphasizing the role of estradiol in mitigating cognitive risks. This study sheds light on the importance of hormonal balance in addressing cognitive impairments associated with cancer treatment. [Extracted from the article]

A recent study conducted at Lakehead University in Thunder Bay, Canada, explored the influence of estradiol, progesterone, and testosterone on mating behavior across the menstrual cycle. The study developed the Proactive and Responsive Mating Strategies Scales (PARMSS) to examine the associations between hormones and mating intentions. Results showed that increases in estradiol and testosterone were linked to higher short-term responsive mating intentions, particularly with potential short-term partners. The findings suggest that hormonal changes may impact mating intentions differently based on the context and require further research with larger and diverse samples. [Extracted from the article]

A recent study conducted by researchers at the University of Washington found that higher levels of FSH (follicle-stimulating hormone) are associated with an increased risk of hip fracture in older adults, independent of sex hormones. The study, which included 295 participants, concluded that higher FSH levels were linked to a significantly higher risk of incident hip fracture, even after adjusting for age, sex, and other hormone levels. These findings suggest a potential direct impact of FSH on bone health and aging, highlighting its role in fracture risk beyond traditional sex hormone levels. [Extracted from the article]

A recent study conducted at the Reproductive Center found that high maternal estradiol levels during early pregnancy, particularly after in vitro fertilization (IVF), are associated with an increased risk of glucose metabolic dysfunction in offspring. The research included 500 children aged 3 to 10 years, comparing those born after fresh embryo transfer, frozen embryo transfer, and natural conception. Children born after fresh IVF showed higher fasting glucose/insulin levels, increased insulin resistance, and a higher incidence of impaired fasting glucose, potentially linked to higher maternal estradiol levels. The study suggests that further research is needed to understand the underlying mechanisms of these metabolic risks in IVF-conceived children. [Extracted from the article]

Researchers at Urmia University conducted a study on the effects of low-intensity suspension training with blood flow restriction (LITRX+BFR) versus high-intensity TRX training (HITRX) on young women's sex hormones, muscular hypertrophy, power, and balance. The study involved 36 active female students who were divided into training groups and a control group. Results showed that both LITRX+BFR and HITRX led to significant improvements in sex hormone levels, muscular hypertrophy, power, and balance, suggesting that LITRX+BFR could be a viable alternative to HITRX for young females. The study was published in Women's Health Bulletin and can be accessed for further information. [Extracted from the article]

A study conducted at the Second Affiliated Hospital of Zhejiang University School of Medicine in Hangzhou, China, explored the impact of high maternal estradiol levels during early pregnancy on the glucose metabolism of offspring conceived through in vitro fertilization (IVF). The research found that children born after fresh embryo transfer (ET) showed higher fasting glucose/insulin levels, increased insulin resistance, and a higher incidence of impaired fasting glucose compared to naturally conceived children. The study suggests that high maternal estradiol levels in early pregnancy may be associated with altered glucose metabolism and increased metabolic risks in IVF-conceived children, highlighting the need for further research to understand the underlying mechanisms. [Extracted from the article]

A study conducted by the Second Affiliated Hospital of Fujian Medical University in Quanzhou, China, examined the relationship between sex steroid hormones and high-sensitivity C-reactive protein (hs-CRP) levels in American children and adolescents using data from NHANES 2015-2016. The research found conditional associations between testosterone, estradiol, sex hormone-binding globulin (SHBG), and hs-CRP levels in different populations. The study concluded that the association between sex steroid hormones and hs-CRP levels is influenced by multiple factors. For more information, the research can be found in Frontiers in Endocrinology, 2024;15:1431984. [Extracted from the article]

The patent application titled "Composition, Formulations And Methods Of Making And Using Botanicals And Natural Compounds For The Promotion Of Healthy Brain Aging" by Morris Notelovitz discusses the physiological changes associated with aging brains and the factors influencing healthy brain aging. The application proposes compositions containing Huperzine A, estrogens/phytoestrogens, and vitamin D to promote healthy brain aging and prevent cognitive decline. The patent application also outlines methods for inhibiting neuronal degeneration, promoting neurogenesis, and maintaining brain health through the administration of the proposed compositions. [Extracted from the article]

Research from Cangzhou Central Hospital explores the therapeutic effects of Althaea officinalis L. and metformin on polycystic ovary syndrome (PCOS) in rats. The study found that the combination of Althaea officinalis L. and metformin can enhance the hypothalamic-pituitary-ovary axis with anti-inflammatory and antioxidant effects, while also inducing apoptosis in cystic granulosa cells. This research provides new insights into the PI3K/AKT pathway, inflammation, and oxidative stress in PCOS treatment. [Extracted from the article]

The research article from the Faculty of Pharmacy discusses the global public health issue of osteoporosis, particularly among aging populations, with a focus on postmenopausal women. The study explores the potential of compounds from Acanthus ilicifolius to inhibit estrogen receptor alpha (ERa) degradation via the CUL4B-DDB1-AhR pathway for antiosteoporosis discovery. Acteoside was identified as a promising candidate for inhibiting ERa degradation, suggesting its potential as an antiosteoporosis agent, although further studies are needed to confirm these findings. The research utilized molecular docking analysis to predict the efficacy of various compounds in inhibiting ERa degradation. [Extracted from the article]

A recent study conducted by researchers at the Department of Family Medicine evaluated the effectiveness of injections of autologous platelet-rich plasma (PRP) into facial skin. The study involved 50 women aged 20 to 52 years, and results showed that 56% of patients displayed improvement in midface volume, particularly those with lower blood platelet counts and higher levels of estradiol. While subjective assessments by doctors and patients indicated some improvement in skin condition, objective data from a facial skin analyzer did not show statistically significant changes. The study found no undesirable effects after the procedure. [Extracted from the article]

A recent study conducted by researchers at the University of Minnesota examined the association between endogenous sex hormones and adiposity (body fat) in youth across a weight status spectrum. The study found that sex hormones, such as testosterone and estradiol, were associated with adipose tissue deposition in youth, regardless of weight status. The findings suggest that sex hormones play a role in regulating body fat distribution in young people. This research was funded by the NIH and has been peer-reviewed. [Extracted from the article]

A new report discusses the findings of a study on hormone replacement therapy conducted by researchers at Troikaa Pharmaceuticals Ltd. The study focuses on the balance between testosterone and estradiol, two major sex steroids, and how this balance is affected by various factors. The researchers highlight the limitations in measuring and defining normative data for the testosterone:estradiol ratio in men. They conclude that further research is needed to clarify measurement strategies and outcome measures related to this ratio. The full report can be accessed in The World Journal of Men's Health. [Extracted from the article]

A recent study conducted by the University of Kebangsaan in Malaysia examined the prevalence of low energy availability (LEA) among Malaysian national athletes and its impact on health-related outcomes. LEA occurs when an athlete's energy intake does not match the energy expended during exercise, leading to insufficient energy for optimal health. The study found that 12 out of 43 athletes showed evidence of LEA, with hormone imbalances being a significant factor. The researchers emphasize the importance of awareness and early detection of LEA among athletes for appropriate intervention. [Extracted from the article]

A recent study conducted at Ankara Bilkent City Hospital in Turkey compared the efficacy of vaginal progesterone gel (VAG) and intramuscular progesterone (IMP) for luteal phase support in suboptimal responders undergoing assisted reproductive cycles. The study analyzed data from 2420 assisted reproductive technology cycles and found no statistically significant differences in pregnancy outcomes between the two groups. The researchers concluded that VAG and IMP provide similar pregnancy outcomes in these patients. This information may be useful for individuals undergoing assisted reproductive treatments. [Extracted from the article]

A recent study conducted by researchers in the Department of Pharmaceutical Analysis focused on ethinyl estradiol therapy. The researchers developed a simple and accurate method for estimating the levels of ethinyl estradiol and etonogestrel in pharmaceutical dosage forms. The study found that the method was effective in determining the retention times and run times of the two substances, making it a cost-effective option for quality control tests in industries. The research provides valuable insights for those interested in hormone replacement therapy and contraceptive drugs. [Extracted from the article]

A report from Nanning Normal University in the People's Republic of China discusses the synthesis and antiproliferative activity of 7-substituted amide estradiol derivatives. The researchers synthesized various amine derivatives of estradiol with a side chain at the 7-position and evaluated their anti-tumor activities. The compounds showed excellent activity, with shorter chains being more active than longer chains. Compound 9o was found to effectively inhibit the proliferation and migration of MCF-7 cells and induce early apoptosis in breast cancer tumors under certain concentration conditions. This research has been peer-reviewed. [Extracted from the article]

A recent study conducted by researchers from Alfaisal University in Riyadh, Saudi Arabia, examined the impact of vitamin D supplementation on male fertility. The study found that vitamin D supplementation significantly increased total testosterone levels in men. However, it did not have a significant effect on other reproductive hormone parameters such as free testosterone, follicle-stimulating hormone, luteinizing hormone, sex-hormone-binding globulin, and estradiol. The researchers concluded that further well-designed randomized controlled trials are needed to determine the effects of vitamin D on these other hormone parameters. [Extracted from the article]

A patent application has been submitted for a method and device that uses levonorgestrel, a synthetic progestin, for contraception and the treatment of endometriosis. The proposed method involves administering levonorgestrel vaginally in doses ranging from 60 mg/day to 100 mg/day for contraception and from 60 mg/day to 160 mg/day for endometriosis treatment. The goal is to achieve effective contraception while minimizing side effects. However, further research is needed to determine the safety and effectiveness of this method. The patent application also describes a device made of polymers that releases a specific amount of levonorgestrel over a 28-day treatment cycle. [Extracted from the article]

A patent application has been filed for a method and device that uses levonorgestrel to provide contraception. Levonorgestrel is a synthetic progestin that prevents ovulation and reduces sperm permeability. The goal of the patent application is to create a contraceptive with high ovulation inhibition effectiveness while minimizing side effects. The method involves continuously administering levonorgestrel vaginally in specific doses, and the device is a drug delivery device that releases levonorgestrel at a controlled rate over a 28-day cycle. The patent application also provides information on the dosage, administration route, and release profile of the device. [Extracted from the article]

A study conducted by researchers at the Royan Institute for Biotechnology in Esfahan, Iran, has found that vitamin D deficiency (VDD) affects sex hormones and testicular function in mice. The study aimed to evaluate the genomic effects of vitamin D on steroidogenesis, sperm structure, and function in mice models with artificially induced VDD. The researchers observed a linear decrease in the expression of steroidogenic genes with increasing severity of VDD, as well as reduced levels of luteinizing hormone, estradiol, and testosterone in cases of mild and moderate VDD. The study suggests that VDD has significant effects on testicular steroidogenesis, which directly impacts spermatogenesis. [Extracted from the article]

A recent study conducted by Hangzhou Medical College explores the relationship between the protein Klotho and metabolic syndrome (MetS) in adults. MetS is a collection of conditions that increase the risk of cardiovascular disease and diabetes. The study found that lower levels of Klotho were associated with factors such as advanced age, male sex, tobacco use, elevated triglycerides, renal insufficiency, inflammation, low estradiol, and low sex hormone-binding globulin (SHBG). The association between Klotho and MetS was more pronounced in women, particularly in relation to waist circumference and triglyceride levels. However, there were gender-specific differences in other factors associated with Klotho. The study concludes that Klotho levels exhibit gender disparities and that triglycerides are the major component of MetS independently associated with Klotho, especially in women. The study suggests that HDL cholesterol is the male-specific MetS component independently associated with Klotho. [Extracted from the article]

A recent study conducted at Recep Tayyip Erdogan University examined the variations in anterior segment parameters among different phenotypes of polycystic ovary syndrome (PCOS). The study included 116 women with PCOS and 29 healthy women in the control group. The researchers found that intraocular pressure (IOP) and central corneal thickness (CCT) were significantly higher in all phenotypes of PCOS compared to the control group. The study suggests that PCOS should be considered an important factor when evaluating female patients for anterior segment diseases and glaucoma. [Extracted from the article]

A recent study conducted by researchers at George Washington University examined the role of biological sex, age, and sex hormones in HIV cure approaches. The study found that IL-15, a cytokine that promotes immune activation and mediates HIV reactivation from latency, had higher activity in female donors compared to male donors. Age was also found to have a positive correlation with IL-15-mediated CD8+ T cell activation and IFN-gamma production. However, biological sex, age, and sex hormones did not influence the ability of IL-15 to reactivate latent HIV in a primary cell model of latency. The researchers concluded that understanding how these biological variables may affect HIV cure therapies will help evaluate clinical trials in diverse populations. [Extracted from the article]

A patent has been issued to Ecofibre USA Inc. for methods of treating estrogen-sensitive diseases with cannabis extract. Estrogens play a role in regulating physiological processes in estrogen-sensitive cells, but changes in estrogen concentration and signaling can lead to diseases such as cancer, osteoporosis, and cardiac disease. The patent describes a cannabis extract containing cannabidiol (CBD) and an estrogen, which can be administered in various ways to treat estrogen-sensitive diseases such as certain types of cancer and endometriosis. The extract can be a full spectrum hemp extract, a broad spectrum hemp extract, a CBD isolate, or cannabidiolic acid (CBDA), and the dosage of CBD can range from 10 mg to 500 mg per dose. [Extracted from the article]

A recent study conducted by researchers at the All India Institute of Medical Sciences (AIIMS) in New Delhi explored the impact of serum estradiol (E2) levels on pregnancy outcomes in artificial autologous frozen thawed embryo transfers. The study found that E2 levels in the range of 301-500 pg/mL before starting progesterone were associated with improved clinical pregnancy rates and live birth rates, as well as decreased miscarriage rates, compared to E2 levels of 300 pg/mL or >500 pg/mL. The findings suggest that maintaining optimal E2 levels may enhance the success of embryo transfer cycles. Further information on the study can be found in the Journal of Human Reproductive Sciences. [Extracted from the article]